Vertex (VERX – Research Report) received a Hold rating and price target from Raymond James analyst Alexander Sklar today. The company’s ...

Fintel reports that on January 3, 2025, Raymond James downgraded their outlook for Vertex (NasdaqGM:VERX) from Outperform to ...

After years of controversy, stem cells are on the cusp of cures for conditions like epilepsy and type 1 diabetes.

Analysts have been eager to weigh in on the Technology sector with new ratings on SPS Commerce (SPSC – Research Report), Stem Inc (STEM – ...

Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory decisions.

The enterprise software space is expected to have a momentous 2025, investment firm Raymond James said in a recent research ...

GEN uncovers seven biopharma-related trends based on interviews with experts and other industry stakeholders, as well as ...

The stock market was rocky at times for local technology companies last year, but some benefited from the volatility. Here's ...

The financial services sector delivers value through automation, fintech innovations, and global economic shifts, creating ...

Apple and Google have removed these six VPN apps from app stores for failing to abide by India’s data laws India has compelled Apple and Google to remove numerous VPN apps, including Cloudflare ...